Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Northwest Biothrputcs Inc (OP:NWBO)

0.1576 -0.0049 (-3.02%)
Delayed Quote Updated: 12:40 PM EDT, Oct 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Northwest Biothrputcs Inc

BioMedNewsBreaks — Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Advances Delivery-Focused Oncology Platform Amid Growing Interest in Drug-Delivery Technologies
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
How Advanced Drug Delivery Could Improve Existing Cancer Treatments
Via Investor Brand Network
InvestorNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Targets CNS Drug Delivery Opportunity as Brain Therapeutics Innovation Accelerates
Via Investor Brand Network
Topics Intellectual Property
Stocks to Watch in May 2023: FOBI.V / FOBIF, NWBO, ENZC, GEVI
Via AB Newswire
Topics Artificial Intelligence
News headline image
How Advanced Drug Delivery Could Improve Existing Cancer Treatments
From BioMedWire
Via GlobeNewswire
News headline image
Biotech Healthcare: CSDX, NWBO, BSEM, RDGL, NRXBF Emerging Stocks to Watch
Via AB Newswire
News headline image
CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities
From BioMedWire
Via GlobeNewswire
12 OTC Stocks to Watch: Clean Vision Corporation (OTCQB: CLNV), NaturalShrimp Inc (OTCQB: SHMP), Northwest Biotherapeutics, Inc. (OTCQB: NWBO), and More
Via AB Newswire
Topics Intellectual Property
Stock Market Surges “Milestones Reached”: SWISF / SKUR.C, NWBO, ENZC, ABML
Via AB Newswire
News headline image
Cohen Milstein Files Lawsuit on Behalf of Northwest Biotherapeutics Against Major Market Makers for Market Manipulation
Via ACN Newswire
Topics Law Enforcement Lawsuit
News headline image
NWBO Stock Alert: Northwest Bio Slams Citadel Securities in New Lawsuit ↗
Shares of NWBO stock are rallying on Thursday, as Northwest Biotherapeutics sues a number of Wall Street firms for stock manipulation. 
Via InvestorPlace
News headline image
A Quick Look At The OTC Markets' Most-Active Securities In August - Here's What You Need to Know ↗
While July gave markets around the world a breather, August reestablished 2022’s choppy financial conditions. 
Via Benzinga
News headline image
These 2 Under-The-Radar Stocks Traded More Than $1B Each Last Month ↗
The month of July saw $37.3 billion in trading volume for stocks that trade on the OTCQK and OTCQB. While some of the stocks that trade over-the-counter are considered penny stocks based on their share... 
Via Benzinga
News headline image
Mortgage Financiers & Crypto Securities Reclaim Their Spots As Most Actively Traded Securities On OTC Markets In June ↗
Reflecting the expected conditions of a bear market, many of the world’s indices saw a decrease in price throughout June. 
Via Benzinga
News headline image
The OTC Markets' Most-Active Securities Embrace International Operators As Volatility Envelops Markets In May ↗
Reflecting the world’s uncertainty about the U.S. economy, the market’s major indices saw incredible volatility in May. 
Via Benzinga
News headline image
If You Invested $1000 In Northwest Biotherapeutics 5 Years Ago, Here's How Much You Would Have Today ↗
Northwest Biotherapeutics (OTC:NWBO) has outperformed the market over the past 5 years by 42.99% on an annualized basis producing an average annual return of 54.57%. Currently, Northwest... 
Via Benzinga
News headline image
Northwest Biotherapeutics, Inc. (OTC:NWBO) Investor Notice: Investigation over Potential Wrongdoing ↗
San Diego, CA -- (SBWIRE) -- 04/28/2021 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Northwest Biotherapeutics, Inc. 
Via SBWire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.